Primer: Takeda Pharmaceutical (4502 JP) - Aug 2026
Takeda is navigating a transitional period, balancing the significant revenue decline from the loss of exclusivity for its ADHD drug Vyvanse...
94 Views
𝛼SK or SearchENTITY
Takeda Pharmaceutical (4502 JP)
Takeda Pharmaceutical (4502 JP)
342
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
morex